Pay in 4 interest-free payments of $23.75 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Adezmapimod (SB 203580) is a selective and ATP-competitive p38 MAPK inhibitor with IC50s of 50 nM and 500 nM for SAPK2a/p38 and SAPK2b/p38β2
Ecdysone receptor (EcR) agonist
75 mm thick
e61350 (2013)
N-Nitroso-N-methylurea is also a precursor in the synthesis of diazomethane
MaxTaq DNA Polymerase (5U/µl) Pack Size:500u Adezmapimod (SB 203580) is aMaxTaq DNA Polymerase is a modified and optimized thermostable enzyme blend containing Taq DNA Polymerase, Pfu DNA Polymerase and enhancing factors. It exhibits the 3' to 5' proofreading activity, resulting in considerably higher amplification fidelity than possible with unmodified Taq DNA Polymerase. Recommended for use in amplification to obtain DNA products up to 20kb.
US$ 156.00
US$ 152.00
US$ 133.20
US$ 156.40
US$ 360.00
US$ 191.00
US$ 208.00
US$ 260.00
US$ 208.00